Literature DB >> 2143751

Pulmonary antibacterial defenses during mild and severe influenza virus infection.

C L Nickerson1, G J Jakab.   

Abstract

Severe influenza virus infections with pneumonic involvement are known to predispose the lungs to bacterial superinfections due to dysfunctions in the alveolar macrophage (AM) phagocytic system. To determine whether milder forms of influenza without pneumonic involvement have a similar outcome, pulmonary antibacterial defenses and AM phagocytosis were compared in murine models of mild and severe influenza virus A/HK/68 infections. Bactericidal activity was quantitated by the intrapulmonary killing of Staphylococcus aureus following aerosol challenge, whereas the functional capacity of the AMs was determined by Fc-receptor-mediated phagocytosis. With the severe virus infection, maximal suppression of bactericidal activity occurred on day 8 of infection and correlated with impairment of AM phagocytosis. A lesser but significant degree of suppression of pulmonary antibacterial defenses and AM phagocytosis was observed on the third day of the mild virus infection. The data demonstrate that mild influenza virus infections that are limited to the upper respiratory tract also impair pulmonary antibacterial defenses and may predispose the lungs to bacterial superinfections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143751      PMCID: PMC313571          DOI: 10.1128/iai.58.9.2809-2814.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza.

Authors:  D B LOURIA; H L BLUMENFELD; J T ELLIS; E D KILBOURNE; D E ROGERS
Journal:  J Clin Invest       Date:  1959-01       Impact factor: 14.808

2.  Alterations in lung macrophage immune receptor(s) activity associated with viral pneumonia.

Authors:  G A Warr; G J Jakab; J E Hearst
Journal:  J Reticuloendothel Soc       Date:  1979-10

3.  Suppression of pulmonary antibacterial activity following Sendai virus infection in mice: dependence on virus dose.

Authors:  G J Jakab
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

Review 4.  Microbial synergism in human infections (second of two parts).

Authors:  P A Mackowiak
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

5.  Interaction of influenza virus with leukocytes and its effect on phagocytosis.

Authors:  W D Sawyer
Journal:  J Infect Dis       Date:  1969-06       Impact factor: 5.226

6.  Influenza and the interaction of viruses and bacteria in respiratory infections.

Authors:  C G Loosli
Journal:  Medicine (Baltimore)       Date:  1973-09       Impact factor: 1.889

7.  Sources of variance in the measurement of intrapulmonary killing of bacteria.

Authors:  D Ruppert; G J Jakab; D L Sylwester; G M Green
Journal:  J Lab Clin Med       Date:  1976-03

Review 8.  Methods to quantify endocytosis: a review.

Authors:  R I Kavet; J D Brain
Journal:  J Reticuloendothel Soc       Date:  1980-02

9.  Effects of low- and high-passage influenza virus infection in normal and nude mice.

Authors:  P R Wyde; R B Couch; B F Mackler; T R Cate; B M Levy
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages.

Authors:  D Warshauer; E Goldstein; T Akers; W Lippert; M Kim
Journal:  Am Rev Respir Dis       Date:  1977-02
View more
  32 in total

Review 1.  The impact of successive infections on the lung microenvironment.

Authors:  Arnaud Didierlaurent; John Goulding; Tracy Hussell
Journal:  Immunology       Date:  2007-12       Impact factor: 7.397

2.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

3.  Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Authors:  Michael S Chaussee; Heather R Sandbulte; Margaret J Schuneman; Frank P Depaula; Leslie A Addengast; Evelyn H Schlenker; Victor C Huber
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

4.  Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza.

Authors:  Wilbur H Chen; Franklin R Toapanta; Kari Ann Shirey; Lei Zhang; Angeliki Giannelou; Carly Page; Matthew B Frieman; Stefanie N Vogel; Alan S Cross
Journal:  Immunol Lett       Date:  2011-10-20       Impact factor: 3.685

5.  Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.

Authors:  Trung Nguyen; Ursula G Kyle; Nancy Jaimon; M Hossein Tcharmtchi; Jorge A Coss-Bu; Fong Lam; Jun Teruya; Laura Loftis
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

6.  Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.

Authors:  Janice L Speshock; Nicole Doyon-Reale; R Rabah; Melody N Neely; Paul C Roberts
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  Actinobacillus pleuropneumoniae culture supernatants interfere with killing of Pasteurella multocida by swine pulmonary alveolar macrophages.

Authors:  W B Chung; L Bäckström; J McDonald; M T Collins
Journal:  Can J Vet Res       Date:  1993-07       Impact factor: 1.310

Review 8.  Immune dysfunction and bacterial coinfections following influenza.

Authors:  Dennis W Metzger; Keer Sun
Journal:  J Immunol       Date:  2013-09-01       Impact factor: 5.422

9.  Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain.

Authors:  Danielle Califano; Yoichi Furuya; Dennis W Metzger
Journal:  J Immunol       Date:  2018-05-14       Impact factor: 5.422

10.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.